Skip to content
Home/Companies/HealthTech/Patient21
PA

Patient21

HealthTech·Germany·Active·4yr hold

Patient21 is a HealthTech company, headquartered in Germany.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Patient21?

Patient21 is currently owned by Target Global through Target Global Early Stage Fund III (2022 vintage), since 2022.

Hand-verified · updated 2026-07-07

Target Global
Investor
Target Global
Target Global Early Stage Fund III · 2022 · VC

Key facts

HQGermany
SectorHealthTech
StatusActive

More from Target Global Early Stage Fund III

Other portfolio companies in the same fund.

Robovision
Active
AI/MLBelgium· 2024
Saleor
Active
SoftwarePoland/USA· 2024
Communion
Active
FintechUK· 2023
Enter
Active
SoftwareGermany· 2023
Ferry
Active
AI/MLUK· 2023
Graphiti
Active
AI/MLIsrael· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings